Nitric oxide inhibition abolishes sleep-wake differences in cerebral circulation

Area of Science:

• Neuroscience
• Physiology
• Sleep Research

Background:

• Nitric oxide (NO) is produced by active neurons and acts as a cerebral vasodilator.
• NO may link brain activity and cerebral blood flow (CBF) during sleep, particularly active sleep (AS).
• AS is characterized by high neural activation and elevated CBF compared to quiet wakefulness (QW) and quiet sleep (QS).

Purpose of the Study:

• To investigate the role of NO in regulating CBF and cerebral vascular resistance (CVR) across different sleep-wake states.
• To determine if NO is the primary factor responsible for CBF variations between sleep stages.

Main Methods:

• Measurements of CBF and CVR in lambs (n=6) during natural sleep-wake cycles.
• Administration of N(omega)-nitro-L-arginine (L-NNA), a nitric oxide synthase inhibitor.
• Comparison of CBF and CVR before and after L-NNA infusion across active sleep (AS), quiet sleep (QS), and quiet wakefulness (QW).

Main Results:

• L-NNA infusion increased CVR and decreased CBF in all states, with the most significant changes observed during AS (CVR increase: 88%, CBF decrease: 24%).
• The distinct CBF and CVR patterns across sleep-wake states vanished within 1-3 hours of L-NNA administration.
• These state-specific differences reappeared by 24 hours, despite ongoing cerebral vasoconstriction.

Conclusions:

• NO is crucial for maintaining cerebral vasodilation during both sleep and wakefulness, particularly in active sleep.
• NO significantly influences, but is not the sole factor in, the CBF differences observed between sleep-wake states.